4100F Biphos thxpy vein ord/recvd
Also known as: bisphosphonate therapy measure, bone therapy measure, osteoporosis treatment tracking
Performance measure code indicating that bisphosphonate therapy was ordered or received by a patient.
In Plain Language
bone strengthening medication given; osteoporosis medication prescribed; bone treatment recorded
Clinical Context
Quality measure for patients at risk for bone loss or with osteoporosis. Tracks initiation or continuation of bisphosphonate therapy like alendronate, risedronate, or ibandronate.
RVU Information
CPT 4100F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4100F?
CPT 4100F (Biphos thxpy vein ord/recvd) is a Other code. Performance measure code indicating that bisphosphonate therapy was ordered or received by a patient.
Who uses CPT code 4100F?
CPT 4100F is used by Rheumatology, Orthopedic Surgery, Internal Medicine. Quality measure for patients at risk for bone loss or with osteoporosis. Tracks initiation or continuation of bisphosphonate therapy like alendronate, risedronate, or ibandronate.
When is CPT 4100F used?
Quality measure for patients at risk for bone loss or with osteoporosis. Tracks initiation or continuation of bisphosphonate therapy like alendronate, risedronate, or ibandronate.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.